Clinical Research Directory

Inclusion Criteria: * Patient with GI malignancy * Provider plans non-curative intent treatment with either CAPOX or FOLFOX (mFOLFOX6) at standard dosages for \>3 months NOTE: Patient is not required to have radiologically measurable disease. NOTE: Planned administration of other anti-cancer medications (eg bevacizumab, epidermal growth factor receptor antibodies, immunotherapy, tyrosine kinase inhibitors) is allowed. Exclusion Criteria: * Patients not meeting standard hematologic parameters for chemotherapy administration as follows: * Absolute neutrophil count (ANC) ≥ 1500 * Platelet count ≥ 100,000 Patients not meeting standard liver function parameters for chemotherapy administration as follows: * AST ≤ 5x ULN * ALT ≤ 5X ULN * Total Bilirubin ≤ 1.5X ULN Patients not meeting standard renal function parameters for chemotherapy administration as follows: * Serum Creatinine ≤ 1.2 or creatinine clearance ≥ 30 ml/min NOTE: Planned administration of another cytotoxic chemotherapy (eg irinotecan) is an exclusion.